Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

28 results found for Oncology in London

Sort by:
Showing 1 - 10 of 28 results
Oncology
25 years of experience
Clinical Oncology

Dr Stephen Morris is a consultant in Clinical Oncology at Guy's and St Thomas' Hospitals, specialising in the management of skin and urological cancers. He specialises in brachytherapy, external beam radiotherapy and chemotherapy for prostate cancer at Guys Hospital. He also leads the chemotherapy and radiotherapy service for cutaneous lymphoma at the St Johns Institute of dermatology at Guys.

Dr Morris completed his initial medical training at Guy's and St Thomas' medical school. Following this, he trained in clinical oncology at the Royal Marsden Hospital and the Guy's and St Thomas' Cancer Centre. At Guys he was involved in setting up the dynamic prostate brachytherapy service and since his appointment as a consultant, has continued to innovate in the field, working for ever-improving outcomes for patients.

In addition to his work in research and clinical trials, he has led the design and implementation of a new modern Total Skin Electron Beam technique for cutaneous lymphoma, IMRT and IGRT for prostate cancer and more recently has developed and implemented the use of the SpaceOAR and Auto Beam Hold intra fraction IGRT technique for prostate cancer. Dr Morris is also a keen teacher and involved in education as a tutor for clinical oncology.


Diseases, Medical Tests and Treatments
  • Prostate brachytherapy
  • Radiotherapy
  • Chemotherapy
  • Clinical Trials
  • Urological oncology 
  • Dermatological oncology
  • Cutaneous lymphoma and melanoma
  • Prostate cancer

 

Read more

Professor Elinor Sawyer is a Consultant Clinical Oncologist with a specialist interest in the treatment of breast cancer. She is based at Guy’s & St Thomas’ Hospital but also performs private work and is Professor in Oncology at King’s College London.

She completed her clinical oncology training at University College London, Royal Free and St Thomas’ Hospitals. Following this, she obtained her PhD in molecular genetics of cancer at the London Research Institute. In 2005 she was appointed as a Consultant Oncologist at Guy’s & St Thomas’ Hospital.


As well as her clinical practice, Professor Sawyer is heavily involved in research and her work has been published in a number of peer reviewed journals. Her main areas of research include genetic predisposition to breast cancer, particularly lobular breast cancer and pre invasive cancer (DCIS and LCIS), and identification of biomarkers that predict progression of early breast cancer.


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Immunotherapy 
  • Breast Cancer 
Read more
Oncology
30 years of experience
Clinical Oncology

Professor Andrew Tutt is a Consultant Clinical Oncologist specialising in breast cancer. He is based at Guy’s Hospital Breast Unit but also performs private work and is a Professor of Oncology at King’s College London School of Medicine.

He qualified in medicine in 1990 and went on to complete his postgraduate training at a number of hospitals around the UK. After completing his clinical oncology training at the Royal Marsden Hospital London, he was awarded a Doctoral Research Training Fellowship at The Institute of Cancer Research, London, where he gained his PhD in cancer biology.

Professor Tutt is actively involved in clinical research and has published a number of breast cancer research papers. His main areas of research include the ‘triple negative’ and BRCA1 and BRCA2 associated breast cancers. He has led a number of international trials of drug therapies and research programmes in these areas.

He is often asked to speak at major European and North American Cancer Medicine conferences. He is a member of the St Gallen International Breast Cancer Consensus Panel that develops guidelines for the treatment of breast cancer. He is also part of a UK team that trial new techniques in breast radiotherapy.


Diseases, Medical Tests and Treatments
  • Biological Therapy 
  • Chemotherapy 
  • Radiotherapy 
  • Breast Cancer 
Read more

Professor Peter Schmid is the Clinical Director of the St. Bartholomew Breast Cancer Centre, and Honorary Consultant Medical Oncologist and lead of the Cancer Immune Therapy group at Barts Hospital. He is also Professor of Cancer Medicine and Lead of the Centre of Experimental Cancer Medicine at Barts Cancer Institute.

Professor Schmid studied medicine in Munich and Aberdeen. He was awarded scholarships by the German National Academic Foundation, the German Academic Exchange Service and the Hanns-Seidel-Foundation. Following this he completed specialist training in internal medicine, medical oncology and haematology in Berlin. Subsequently he undertook an MD in Clinical Chemistry at the Technical University Munich and a PhD in Medical Oncology at the Charité University in Berlin. In 2005, Professor Schmid moved to the UK and was appointed as Senior Clinical Lecturer and Director of the Hammersmith Early Clinical Trials Unit at Imperial College London. He was subsequently made Foundation Chair in Cancer Medicine at the University of Sussex.

He specialises in breast cancer, lung cancer and cancer immune therapy and is renowned internationally for this work in cancer immunotherapy. He was instrumental in the formation of the Cancer Immune Therapy group at Barts Hospital, which has become recognised globally as a leader in this field.

Professor Schmid has a particular research interest in triple negative breast cancer and endocrine resistance and has led more than 20 clinical studies and several translational research programmes in these areas. He also has an interest in personalised cancer medicine using novel biomarkers and innovative, biomarker-driven clinical trial strategies to develop new treatment strategies. He currently leads an international group to establish blood-based circulating biomarkers.

He has authored or co-authored more than 150 publications and has published a book on the management of bone metastases. He is also regularly invited to speak at major international cancer conferences. Professor Schmid is a member of the breast cancer faculty of the European Society of Medical Oncology and has chaired several medical research committees. He was awarded the Breast Cancer Research Award 2012 by German Patient group Mammazone.

Professor Schmid has a strong interest in patient-doctor communication, for a number of years, he ran a programme training oncologists and oncology nurses in communication.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Immunotherapy 
  • Breast Cancer
  • Lung Cancer 
Read more

George Mikhaeel is a Professor of Radiation Oncology at King’s College London and Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Foundation Trust since 2001. He specialises in the treatment of lymphoma with both chemotherapy and radiotherapy and has extensive experience in advanced radiotherapy techniques for haematological malignancies.

Professor Mikhaeel’s research has resulted in new ways of treating lymphoma patients with radiotherapy, harnessing the benefits of advances in radiotherapy technology and advances in imaging. An example of new treatments is combining an innovative arc technique and deep inspiration breath-hold (DIBH) with image-guided delivery of treatment to improve the accuracy of targeting radiation and reduce dose to healthy tissues.

His clinical practice is focused only on haematological malignancies which are less common and require a high level of specialisation and substantial clinical experience, having practised in this field for more 20 years. Professor Mikhaeel has lectured in more than 15 countries and has numerous publications in the field including four influential international guidelines.

He is a founding member of the International Lymphoma Radiation Oncology Group (ILROG) and a member of its steering and executive committees. Professor Mikhaeel also chairs the haematology track for the American Society of Radiation Oncology (ASTRO) annual meeting scientific committee and a reviewer for the European Society of Radiation Oncology (ESTRO). Nationally, he is the chair of the UK Lymphoma Radiotherapy Group (UK-LRG) steering committee.


Diseases, Medical Tests and Treatments


  • Radiotherapy
  • Chemotherapy


  • Haematological malignancies
Read more
Oncology
25 years of experience
Medical Oncology

Dr Rebecca Kristeleit is a Clinical Senior Lecturer and Consultant Medical Oncologist at UCL/UCLH. She specialises in the treatment of gynaecological cancers such as cervical cancer, endometrial cancer, and ovarian cancer. She also has a specialist interest in drug development as well and is leading several clinical trials of novel agents relevant to gynaecological malignancies including PARP inhibitors.

Dr Kristeleit qualified in medicine from St Andrew’s and Manchester Universities including eight months at the University of Lausanne (Switzerland) on an Erasmus scholarship. Following general medical training in London, she undertook my medical oncology training at The Royal Marsden Hospital and a CRUK-funded research fellowship at the Institute of Cancer Research. Subsequently, Dr Kristeleit spent a year as a senior research fellow on the Drug Development Unit at the Royal Marsden Hospital gaining specialist experience in the design and conduct of early phase clinical trials and translational medicine.

Dr Kristeleit's research work, as part of the UCLH gynaecological oncology team, Clinical Research Facility at UCLH and the UCL Cancer Institute, is focused on the development of early-phase clinical trials and translational research to identify and evaluate innovative treatment strategies for gynaecological malignancies as well as other solid tumours.


Diseases, Medical Tests and Treatments
  • Cervical cancer
  • Endometrial cancer
  • Ovarian cancer
  • Cervical cancer
  • Endometrial cancer
  • Ovarian cancer
Read more
Oncology
31 years of experience
Clinical Oncology

Lucy Brazil is a Consultant Oncologist who has been with Guy’s and St Thomas’ and King’s College Hospitals since 2005. In 2007, she was awarded an MD for research into breast cancer genetics at the Institute of Cancer Research and Breakthrough Breast Cancer.

Dr Brazil trained in oncology at the Royal Marsden Hospital and Guy’s and St Thomas’ Hospitals. Her specialist interests include neuro-oncology particularly high grade glioblastoma multiforme and low grade glioma including oligodendroglioma and spinal tumours and breast cancer including management of brain metastases. Dr Brazil has expertise in radiotherapy both standard conformal and stereotactic techniques and including Cyberknife, Rapid-Arc and IMRT. She also oversees chemotherapy and endocrine treatments.

Dr Brazil is a member of the NCI National Cancer Institute Brain Tumour Clinical Studies Group and the EORTC European Organisation of Research and Treatment of Cancer Brain Tumour Group. She is chief investigator for the CODEL brain tumour study using chemotherapy and radiotherapy for grade 3 gliomas, chairman of the brain-tumour palliative care sub-group and neuro-oncology research lead at Guy's and St Thomas' in addition to being systemic chemotherapy neuro-oncology lead at the hospital.

 


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • Palliative Care
  • Brain Cancer
  • Breast Cancer
  • Neuro-oncology
Read more
Oncology
29 years of experience
Medical Oncology

Dr Anne Armstrong is a well-respected Consultant Oncologist with HCA Healthcare and Guy's and St. Thomas' NHS Foundation Trust in London where she is the Head of Medical Oncology, along with being the lead for Systemic Treatment of Breast Cancer in South East London.

She graduated with a degree in Psychology and returned to university to study Medicine at the renowned Imperial College London. She completed her medical oncology training at numerous centres of excellence, including the Royal Marsden Hospital and Hammersmith Hospital. Following this she completed pioneering research into the molecular genetics of breast and pancreatic cancer and was awarded a PhD. In 2005 she was appointed her first Consultant post. She remains heavily involved in research, being appointed as chief investigator and of numerous breast cancer trials.


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Hormonal Therapy
  • Endocrine Therapy
  • Breast Cancer
Read more
Oncology
23 years of experience
Medical Oncology

Dr Sarker is a Senior Lecturer and Honorary Consultant in Medical Oncology at Guy’s and St Thomas’ NHS Foundation Trust, and King’s College Hospital NHS Foundation Trust. He specialises in the treatment of hepato-pancreatic-biliary malignancies: Liver Cancer, Bile Duct Cancer, Pancreatic Cancer, Neuro-endocrine Cancer, Adrenal Glands Cancer and Gall Bladder Cancer.

His main research focus is in the development of novel therapies for cancer, and together with Dr James Spicer, runs the Early Phase Clinical Trials Unit based at Guy’s Hospital. He is also actively involved in the management of hepato-pancreatic-biliary malignancies at King's College Hospital Liver Unit, and has a specific interest in the development of new therapies and molecular imaging for these tumours. Dr Sarker graduated in medicine from the University of Liverpool in 1997, and subsequently trained in internal medicine and medical oncology. In 2003 he was appointed to a Cancer Research UK Clinical Research Fellowship in the Drug Development Unit of The Royal Marsden Hospital and Institute of Cancer Research, leading to the award of a PhD. He completed his medical oncology training at The Royal Marsden in 2010.

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Molecular Imaging
  • Gastro-intestinal cancers
  • Neuro-endocrine cancers
  • Liver cancer
  • Bilary cancer
Read more
Oncology
19 years of experience
Clinical Oncology

Dr Asad Qureshi is a Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust. In his NHS and private practice, he specialises in the treatment of upper and lower gastro-intestinal and non-melanoma skin cancers: Oesophageal Cancer, Stomach Cancer, Colon Cancer, Rectal Cancer, Radiotherapy for non-melanomatous skin cancer, Chemotherapy and SABR. Dr Qureshi is the Clinical Lead for out-patients in the Cancer Centre at Guy’s Hospital, London and is a member of the Senior Oncology Management Team. He is also the Clinical Oncology and Radiotherapy Audit Lead and the Clinical Oncology Oesophago-gastric lead.

He trained at St Bartholomew’s and The Royal London Hospitals medical schools where he gained a BSc in neurosciences. He completed his specialist training in Clinical Oncology at a number of specialist departments in London, including Guy’s and St Thomas’ Hospital, Charing Cross Hospital, St Bartholomew’s Hospital and The Royal Marsden Hospital. During his training spent two years working in the Imaging Sciences Laboratories at Kings College London, and the Centre for Medical Image Computing at University College London assessing novel radiotherapy techniques for the treatment of mobile tumours. Dr Qureshi plays an active role in research and is a Principle Investigator on a number of national clinical trials. His research interests include Stereotactic Radiotherapy (SABR), Image-guided Radiotherapy (IGRT) and dose escalation of radiotherapy and he has published a number of papers in this field.Dr Qureshi is committed to medical education. He is a clinical and educational supervisor for Clinical Oncology trainees at Guy’s and St Thomas’ NHS Foundation Trust. He is also a Medical Supervisor for radiographers on prescribing courses.


Diseases, Medical Tests and Treatments
  • External Beam Radiotherapy (IMRT and IGRT)
  • Chemotherapy
  • Radiotherapy
  • Stereotactic Radiotherapy (Including CyberKnife)
  • Colorectal Cancer
  • Anal Cancer
  • Oesophageal Cancer
  • Gatro-intestinal Cancers
  • Stomach Cancer
Read more